Genetic Analysis Overview

  • Founded
  • 2008

Founded
  • Status
  • Public

  • Employees
  • 21

Employees
  • Stock Symbol
  • GEAN

Stock Symbol
  • Share Price
  • $0.16

  • (As of Monday Closing)

Genetic Analysis General Information

Description

Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.

Contact Information

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Stock Exchange
SAT
Primary Office
  • Kabelgata 8
  • 0580 Oslo
  • Norway
+47 483 00 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genetic Analysis Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.16 $0.16 $0.15 - $1.56 $3.84M 24.9M 29K -$0.12

Genetic Analysis Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 2,819 16,572
Revenue 1,111 788 611 829
EBITDA (2,528) (2,822) (1,665) (483)
Net Income (3,089) (3,363) (2,339) (788)
Total Assets 7,085 9,465 6,515 5,169
Total Debt 120 333 336 317
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Genetic Analysis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genetic Analysis‘s full profile, request access.

Request a free trial

Genetic Analysis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to t
Laboratory Services (Healthcare)
Oslo, Norway
21 As of 2021
00.000
00.00 0000-00-00
00000000 00.000

000000

consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut e
0000 000000000
Boston, MA
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genetic Analysis Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 Venture Capital-Backed Boston, MA 00 0000 00000000000 0000
You’re viewing 1 of 1 competitors. Get the full list »

Genetic Analysis Patents

Genetic Analysis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202204013-D0 Method of culture Pending 22-Mar-2022
GB-202204015-D0 Method of culture Pending 22-Mar-2022
EP-3526340-A1 A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant Pending 14-Oct-2016 000000000000
US-20220120747-A1 Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant Pending 14-Oct-2016 00000000
CA-3039144-A1 A companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant Pending 14-Oct-2016 G01N33/56916
To view Genetic Analysis’s complete patent history, request access »

Genetic Analysis Executive Team (11)

Name Title Board Seat Contact Info
Ronny Hermansen Chief Executive Officer
Eilert Aamodt Chief Financial Officer
Kari Furu Ph.D Chief Technology Officer
Anita Jusnes Chief Commercial Officer
Kathryn Baker Chairperson
You’re viewing 5 of 11 executive team members. Get the full list »

Genetic Analysis Board Members (12)

Name Representing Role Since
Ashok Shah Genetic Analysis Board Member 000 0000
Camilla Bondesson Genetic Analysis Board Member 000 0000
Kathryn Baker Self Chairperson 000 0000
Rune Sørum Self Board Member 000 0000
Staffan Strömberg Ph.D Genetic Analysis Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Genetic Analysis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genetic Analysis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genetic Analysis‘s full profile, request access.

Request a free trial